Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CoQ10 and Other Substances to be Studied for Parkinson's Disease - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

CoQ10 and Other Substances to be Studied for Parkinson’s Disease

By: Rebecca Wright

Editor/Associate Publisher

According to an Associated Press article, the U.S. government is planning to study substances that may slow the progression of Parkinson’s, instead of just its treating symptoms. CoQ10 will be the first substance evaluated by the National Institutes of Health (NIH), Bethesda, MD. Currently, the AP article said, NIH is finalizing plans to enroll hundreds of early-stage Parkinson’s patients in a study of super-high doses of CoQ10. Along with CoQ10, NIH is also targeting for study an old antibiotic (minocycline) and a muscle-related supplement (creatine) often used by bodybuilders.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters